Thomas Fovet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Thomas Fovet has a total of 241 co-authors. Here are the top co-authors by number of shared publications:
Ali Amad
Univ. Lille, INSERM U1172, CHU Lille, Centre Lille Neuroscience & Cognition (INTERACTIONS), F-59000 Lille, France; CHU Lille, Pôle de Psychiatrie, F-59000 Lille, France; Department of Neuroimaging, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK
29 shared publicationsPierre Thomas
Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France
24 shared publications- Jean-Arthur Micoulaud-Franchi
CNRS, SANPSY, UMR 6033, University of Bordeaux, Bordeaux, France; University Sleep Clinic, University Hospital of Bordeaux, place Amélie-Raba-Léon, Bordeaux, France
12 shared publications Mathilde Horn
Service de psychiatrie adulte, CHU de Lille, 59000 Lille, France; Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000, Lille, France
12 shared publications- Ali Amad
Univ. Lille, Inserm, CHU Lille, U1172 – Lille Neuroscience & Cognition
11 shared publications Marielle Wathelet
Agence régionale de santé (ARS) des Hauts-de-France, Lille, France; Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000, Lille, France
11 shared publications
Latest Publications
- 30 May 2026
- Published by SAGE Publications in International Journal of Social Psychiatry
Deterioration of Psychiatric Care in French Prisons
- 30 May 2026
- Published by SAGE Publications in International Journal of Social Psychiatry
Deterioration of Psychiatric Care in French Prisons
- 2 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Détection automatisée des hallucinations auditives en IRM fonctionnelle et perspectives thérapeutiques dans la schizophrénie
L’hallucination est une expérience subjective vécue en pleine conscience consistant en une perception impossible à distinguer d’une perception réelle, mais survenant en l’absence de tout stimulus en provenance de l’environnement externe. Les symptômes hallucinatoires, qui peuvent concerner toutes les modalités sensorielles, sont retrouvés dans divers troubles neurologiques et psychiatriques mais également chez certains sujets indemnes de toute pathologie. Dans le champ de la psychiatrie, la pathologie la plus fréquemment associée aux hallucinations reste la schizophrénie et la modalité auditive est la plus représentée, puisque 60 à 80% des patients souffrant de ce trouble sont concernés. Le retentissement fonctionnel des hallucinations auditives peut être important, altérant significativement la qualité de vie des patients.Dans ce contexte, la prise en charge de ce type de symptômes s’avère un enjeu considérable pour les personnes souffrant de schizophrénie. Pourtant, les moyens thérapeutiques actuellement disponibles (traitements médicamenteux antipsychotiques notamment) ne permettent pas toujours une rémission complète de la symptomatologie hallucinatoire et l’on considère que 25 à 30% des hallucinations auditives sont « pharmaco-résistantes ». C’est à partir de ce constat que, ces dernières années, ont émergé, pour le traitement des hallucinations auditives, des techniques de neuromodulation comme la stimulation magnétique transcrânienne répétée ou la stimulation électrique transcrânienne par courant continu. Toutefois, les résultats de ces nouvelles thérapies sur les hallucinations auditives résistantes restent modérés et le développement de stratégies alternatives demeure un enjeu de recherche majeur.Actuellement, les travaux en imagerie fonctionnelle permettent d'affiner les modèles physiopathologiques des hallucinations auditives, mais leur intérêt pourrait aller au-delà de la recherche fondamentale, avec possiblement des applications cliniques telles que l'assistance thérapeutique. Ce travail de thèse s’inscrit précisément dans le développement de l’imagerie cérébrale de « capture » des hallucinations auditives, c’est-à-dire l’identification des patterns d’activation fonctionnels associés à la survenue des hallucinations auditives.La première partie de ce travail est consacrée à la détection automatisée des hallucinations auditives en IRM fonctionnelle. L’identification des périodes hallucinatoires survenues au cours d’une session d’IRM fonctionnelle est actuellement possible par une méthode de capture semi-automatisée validée. Celle-ci permet une labellisation des données acquises au cours d’une session de repos en périodes « hallucinatoires » et « non-hallucinatoires ». Toutefois, le caractère long et fastidieux de cette méthode limite largement son emploi. Nous avons donc souhaité montrer comment les stratégies d’apprentissage machine (support vector machine ou SVM, notamment) permettent l’automatisation de cette technique par le développement de classificateurs performants, généralisables et associés à un faible coût de calcul (indispensable en vue d’une utilisation en temps réel). Nous proposons également le développement d’algorithmes de reconnaissance de la période « pré-hallucinatoire », en mettant en évidence que ce type de classificateur présente aussi des performances largement significatives. Enfin, nous avons pu montrer que l’utilisation de stratégies d’apprentissage-machine alternatives au SVM (e.g, le TV-Elastic-net), obtient des performances significativement supérieures au SVM
- 2 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Détection automatisée des hallucinations auditives en IRM fonctionnelle et perspectives thérapeutiques dans la schizophrénie
L’hallucination est une expérience subjective vécue en pleine conscience consistant en une perception impossible à distinguer d’une perception réelle, mais survenant en l’absence de tout stimulus en provenance de l’environnement externe. Les symptômes hallucinatoires, qui peuvent concerner toutes les modalités sensorielles, sont retrouvés dans divers troubles neurologiques et psychiatriques mais également chez certains sujets indemnes de toute pathologie. Dans le champ de la psychiatrie, la pathologie la plus fréquemment associée aux hallucinations reste la schizophrénie et la modalité auditive est la plus représentée, puisque 60 à 80% des patients souffrant de ce trouble sont concernés. Le retentissement fonctionnel des hallucinations auditives peut être important, altérant significativement la qualité de vie des patients.Dans ce contexte, la prise en charge de ce type de symptômes s’avère un enjeu considérable pour les personnes souffrant de schizophrénie. Pourtant, les moyens thérapeutiques actuellement disponibles (traitements médicamenteux antipsychotiques notamment) ne permettent pas toujours une rémission complète de la symptomatologie hallucinatoire et l’on considère que 25 à 30% des hallucinations auditives sont « pharmaco-résistantes ». C’est à partir de ce constat que, ces dernières années, ont émergé, pour le traitement des hallucinations auditives, des techniques de neuromodulation comme la stimulation magnétique transcrânienne répétée ou la stimulation électrique transcrânienne par courant continu. Toutefois, les résultats de ces nouvelles thérapies sur les hallucinations auditives résistantes restent modérés et le développement de stratégies alternatives demeure un enjeu de recherche majeur.Actuellement, les travaux en imagerie fonctionnelle permettent d'affiner les modèles physiopathologiques des hallucinations auditives, mais leur intérêt pourrait aller au-delà de la recherche fondamentale, avec possiblement des applications cliniques telles que l'assistance thérapeutique. Ce travail de thèse s’inscrit précisément dans le développement de l’imagerie cérébrale de « capture » des hallucinations auditives, c’est-à-dire l’identification des patterns d’activation fonctionnels associés à la survenue des hallucinations auditives.La première partie de ce travail est consacrée à la détection automatisée des hallucinations auditives en IRM fonctionnelle. L’identification des périodes hallucinatoires survenues au cours d’une session d’IRM fonctionnelle est actuellement possible par une méthode de capture semi-automatisée validée. Celle-ci permet une labellisation des données acquises au cours d’une session de repos en périodes « hallucinatoires » et « non-hallucinatoires ». Toutefois, le caractère long et fastidieux de cette méthode limite largement son emploi. Nous avons donc souhaité montrer comment les stratégies d’apprentissage machine (support vector machine ou SVM, notamment) permettent l’automatisation de cette technique par le développement de classificateurs performants, généralisables et associés à un faible coût de calcul (indispensable en vue d’une utilisation en temps réel). Nous proposons également le développement d’algorithmes de reconnaissance de la période « pré-hallucinatoire », en mettant en évidence que ce type de classificateur présente aussi des performances largement significatives. Enfin, nous avons pu montrer que l’utilisation de stratégies d’apprentissage-machine alternatives au SVM (e.g, le TV-Elastic-net), obtient des performances significativement supérieures au SVM
- 27 February 2026
- Published by Elsevier in Soins Psychiatrie
- Vol. 47 (363) , 23-27
Risque de violence et psychiatrie en milieu carcéral
- 27 February 2026
- Published by Elsevier in Soins Psychiatrie
- Vol. 47 (363) , 23-27
Risque de violence et psychiatrie en milieu carcéral
- Open Access
- 19 December 2025
- Published by Elsevier in L'Encéphale
- Vol. 52 (4) , 449-451
Prisons de haute sécurité : jusqu’où peut-on soigner en milieu carcéral ?
- 19 December 2025
- Published by Elsevier in L'Encéphale
- Vol. 52 (4) , 449-451
Open AccessPrisons de haute sécurité : jusqu’où peut-on soigner en milieu carcéral ?
- 17 November 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (2) , 1171-1172
No precision psychiatry without clinical precision
- 17 November 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (2) , 1171-1172
No precision psychiatry without clinical precision
- Open Access
- 31 October 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-9
The VigilanS-Prison programme: a pilot study of a brief contact intervention for reducing suicidal behaviours in prisons (2021–2024)
Suicidal behaviour is highly prevalent in prisons. The VigilanS programme is a brief contact intervention that is now recognized as a pillar of France’s national suicide prevention strategy. This study aimed to evaluate the VigilanS-prison intervention, focusing on two aspects: its feasibility and its effectiveness in reducing the rates of suicide attempts (SAs) and suicides in correctional facilities. VigilanS-Prison was launched in June 2021 in two of the 16 correctional facilities for adults in the Hauts-de-France region: Lille-Sequedin and Lille-Annoeullin. The programme expanded to Longuenesse and Vendin-le-Vieil in June 2023 and to Maubeuge in January 2024. The activity of the programme from June 2021 to April 2024 was described. To assess its impact, suicidal behaviours recorded by the prison administration between January 1, 2018, and December 31, 2023, were analysed. Interrupted time series (ITS) analyses compared the monthly rates of SAs and suicides before and after programme implementation in Lille-Sequedin and Lille-Annoeullin. Joint time series analyses compared these trends to those of control facilities. A total of 384 individuals (43 women) were included in VigilanS-Prison due to either a history of SAs in the year prior to detention (n = 83) or following an SA in prison (n = 301). During the study, 1,343 postcards were distributed, with 78 participants (20.3%) responding at least once. Following implementation, the SA rates in Lille-Sequedin and Lille-Annoeullin decreased significantly (-37.31 per 10,000), whereas the suicide rates showed a non-significant reduction (-2.91 per 10,000). Over time, declines in monthly SA (-0.69 per 10,000) and suicide (-0.09 per 10,000) rates were observed but remained non-significant. Comparisons with control facilities revealed no significant differences in immediate or long-term trends. The VigilanS-Prison programme has demonstrated feasibility and an immediate significant reduction in SA rates in intervention facilities. However, its effect on suicide rates was modest and non-significant. The long-term trends suggest potential benefits, although these effects remain non-significant. The specificity of the programme's impact could not be established, given the non-significant results in comparisons with control facilities. Further evaluation with larger datasets collected at the individual level and over a longer follow-up period is needed to confirm the effectiveness of the programme.
- 31 October 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-9
Open AccessThe VigilanS-Prison programme: a pilot study of a brief contact intervention for reducing suicidal behaviours in prisons (2021–2024)
Suicidal behaviour is highly prevalent in prisons. The VigilanS programme is a brief contact intervention that is now recognized as a pillar of France’s national suicide prevention strategy. This study aimed to evaluate the VigilanS-prison intervention, focusing on two aspects: its feasibility and its effectiveness in reducing the rates of suicide attempts (SAs) and suicides in correctional facilities. VigilanS-Prison was launched in June 2021 in two of the 16 correctional facilities for adults in the Hauts-de-France region: Lille-Sequedin and Lille-Annoeullin. The programme expanded to Longuenesse and Vendin-le-Vieil in June 2023 and to Maubeuge in January 2024. The activity of the programme from June 2021 to April 2024 was described. To assess its impact, suicidal behaviours recorded by the prison administration between January 1, 2018, and December 31, 2023, were analysed. Interrupted time series (ITS) analyses compared the monthly rates of SAs and suicides before and after programme implementation in Lille-Sequedin and Lille-Annoeullin. Joint time series analyses compared these trends to those of control facilities. A total of 384 individuals (43 women) were included in VigilanS-Prison due to either a history of SAs in the year prior to detention (n = 83) or following an SA in prison (n = 301). During the study, 1,343 postcards were distributed, with 78 participants (20.3%) responding at least once. Following implementation, the SA rates in Lille-Sequedin and Lille-Annoeullin decreased significantly (-37.31 per 10,000), whereas the suicide rates showed a non-significant reduction (-2.91 per 10,000). Over time, declines in monthly SA (-0.69 per 10,000) and suicide (-0.09 per 10,000) rates were observed but remained non-significant. Comparisons with control facilities revealed no significant differences in immediate or long-term trends. The VigilanS-Prison programme has demonstrated feasibility and an immediate significant reduction in SA rates in intervention facilities. However, its effect on suicide rates was modest and non-significant. The long-term trends suggest potential benefits, although these effects remain non-significant. The specificity of the programme's impact could not be established, given the non-significant results in comparisons with control facilities. Further evaluation with larger datasets collected at the individual level and over a longer follow-up period is needed to confirm the effectiveness of the programme.
- Open Access
- 20 September 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (18) , 2363
Psychiatric Risk Governance Across Jurisdictions: A Comparative Analysis of Involuntary Treatment, Community Treatment Orders, and Forensic Mental Health Services
Background: This article presents an international comparative review of involuntary psychiatric care, Community Treatment Orders (CTOs), and forensic mental health services, with operational implications for Italy. Italy has a community-based model inspired by the “Basaglia Law” (Law No. 180/1978), emphasizing deinstitutionalization and continuity of care. Nevertheless, risk governance gaps persist for high-complexity patients, imposing a disproportionate legal and clinical burden on mental health professionals. This group includes individuals who refuse treatment despite meeting criteria for compulsory admission, patients at elevated risk with substantial management complexity, and offenders with a current or suspected psychiatric disorder. Methods: We conducted a comparative legal and policy review across seven jurisdictions (Italy, England and Wales (UK), France, Germany, Spain, the United States, and Canada) to map frameworks for involuntary treatment, forensic services, CTOs (or equivalents), and community-based risk management. We also extracted procedural safeguards, duration and renewal limits, and interfaces with forensic services. Results: CTOs are available in five of the seven jurisdictions (England and Wales, France, Spain, the United States, and Canada) but are absent in Italy and Germany. We propose a three-pillar framework: (1) enforceable outpatient measures, including CTOs; (2) Forensic Psychiatry Units within Local Health Authorities; and (3) oversight boards with judicial, clinical, and social representatives. These components aim to redistribute responsibility, ensure continuity of care, and provide proportional oversight within a least restrictive, graduated system. Conclusions: When narrowly targeted, time limited, and paired with robust safeguards and service-quality standards, CTOs can support adherence and continuity for patients who repeatedly disengage from care. For Italy, integrating this instrument within the three-pillar framework and under independent oversight could strengthen patient rights and public safety, reduce revolving-door admissions, and improve outcomes.
- 20 September 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (18) , 2363
Open AccessPsychiatric Risk Governance Across Jurisdictions: A Comparative Analysis of Involuntary Treatment, Community Treatment Orders, and Forensic Mental Health Services
Background: This article presents an international comparative review of involuntary psychiatric care, Community Treatment Orders (CTOs), and forensic mental health services, with operational implications for Italy. Italy has a community-based model inspired by the “Basaglia Law” (Law No. 180/1978), emphasizing deinstitutionalization and continuity of care. Nevertheless, risk governance gaps persist for high-complexity patients, imposing a disproportionate legal and clinical burden on mental health professionals. This group includes individuals who refuse treatment despite meeting criteria for compulsory admission, patients at elevated risk with substantial management complexity, and offenders with a current or suspected psychiatric disorder. Methods: We conducted a comparative legal and policy review across seven jurisdictions (Italy, England and Wales (UK), France, Germany, Spain, the United States, and Canada) to map frameworks for involuntary treatment, forensic services, CTOs (or equivalents), and community-based risk management. We also extracted procedural safeguards, duration and renewal limits, and interfaces with forensic services. Results: CTOs are available in five of the seven jurisdictions (England and Wales, France, Spain, the United States, and Canada) but are absent in Italy and Germany. We propose a three-pillar framework: (1) enforceable outpatient measures, including CTOs; (2) Forensic Psychiatry Units within Local Health Authorities; and (3) oversight boards with judicial, clinical, and social representatives. These components aim to redistribute responsibility, ensure continuity of care, and provide proportional oversight within a least restrictive, graduated system. Conclusions: When narrowly targeted, time limited, and paired with robust safeguards and service-quality standards, CTOs can support adherence and continuity for patients who repeatedly disengage from care. For Italy, integrating this instrument within the three-pillar framework and under independent oversight could strengthen patient rights and public safety, reduce revolving-door admissions, and improve outcomes.
- 4 April 2025
- Published by Elsevier in Psychiatry Research
- Vol. 348, 116485
Mental health of prerelease incarcerated women
- 4 April 2025
- Published by Elsevier in Psychiatry Research
- Vol. 348, 116485
Mental health of prerelease incarcerated women